EC approves Incyte’s Minjuvi combo for follicular lymphoma
The EC approval follows the positive opinion issued by the European Medicines Agency’s CHMP in November 2025.
Drug Development
Alnylam plans $250m investment in Norton manufacturing facility, US
Harbour BioMed and BMS sign multi-specific antibody collab
INCOG reveals $200m injectable drug expansion in Indiana
States consider payment limits to curb prescription drug prices with PDABs
LEO Pharma applies to EMA to expand Anzupgo use to adolescents
SK Capital Partners supports Swixx BioPharma’s global expansion
FDA approves Acadia’s Daybue Stix for Rett syndrome
